0001209191-23-014157.txt : 20230301
0001209191-23-014157.hdr.sgml : 20230301
20230301164842
ACCESSION NUMBER: 0001209191-23-014157
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230227
FILED AS OF DATE: 20230301
DATE AS OF CHANGE: 20230301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Szymanska Anna
CENTRAL INDEX KEY: 0001804499
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37939
FILM NUMBER: 23694431
MAIL ADDRESS:
STREET 1: C/O MARKER THERAPEUTICS, INC.
STREET 2: 3200 SOUTHWEST FREEWAY, SUITE 2240
CITY: HOUSTON
STATE: TX
ZIP: 77027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Marker Therapeutics, Inc.
CENTRAL INDEX KEY: 0001094038
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 880277072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4551 KENNEDY COMMERCE DR.
CITY: HOUSTON
STATE: TX
ZIP: 77032
BUSINESS PHONE: (713) 400-6400
MAIL ADDRESS:
STREET 1: 4551 KENNEDY COMMERCE DR.
CITY: HOUSTON
STATE: TX
ZIP: 77032
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC.
DATE OF NAME CHANGE: 20170629
FORMER COMPANY:
FORMER CONFORMED NAME: TAPIMMUNE INC
DATE OF NAME CHANGE: 20070628
FORMER COMPANY:
FORMER CONFORMED NAME: GENEMAX CORP
DATE OF NAME CHANGE: 20020718
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-27
0
0001094038
Marker Therapeutics, Inc.
MRKR
0001804499
Szymanska Anna
C/O MARKER THERAPEUTICS, INC.
4551 KENNEDY COMMERCE DR.
HOUSTON
TX
77032
0
1
0
0
Vice President, Quality
Employee Stock Option (right to buy)
2.14
2023-02-27
4
A
0
29947
0.00
A
2033-02-27
Common Stock
29947
29947
D
This option vests in equal monthly installments over a four year period commencing on March 27, 2023 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
/s/ Michael Loiacono, Attorney-in-Fact
2023-03-01